LGVN

Longeveron Inc.

Company with tickers: LGVN

CIK

1721484

CUSIP

54303L203

Shares Outstanding

31,146,337

Website

https://www.longeveron.com

Investor Relations

https://investors.longeveron.com/overview/default.aspx

13F Activity (30d)

3 filings 2 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-18	New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
2026-06-09	Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
2026-06-04	Longeveron to Present at BIO International Convention 2026
2026-05-20	Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
2026-05-13	Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
2026-05-11	Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)
2026-05-08	Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
2026-05-05	Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
2026-04-08	Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
2026-03-17	Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
2026-03-12	Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

Past events

Date	Event	Type
2026-05-13	Longeveron 2026 First Quarter Financial Results and Business Update Investment Community Call & Webcast	Webcast
2026-03-17	Longeveron 2025 Financial Results and Business Update	Event
2025-11-04	Third Quarter 2025 Financial Results and Business Update	Event
2025-09-08	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-08-13	Q2 2025 Financial Results and Business Update	Event
2025-06-16	H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference	Conference
2025-05-08	Longeveron 2025 First Quarter Financial Results Call	Event
2025-03-18	Roth Conference	Conference
2025-02-28	Longeveron Full Year 2024 Financial Results and Business Update Call	Event
2025-02-19	Emerging Growth Virtual Conference - Feb 2025	Conference
2025-01-14	Longeveron Corporate Presentation at Biotech Showcase 2025	Presentation
2024-12-05	Emerging Growth Virtual Conference - Dec 2024	Conference
2024-11-12	Longeveron 2024 Third Quarter Financial Results Call	Event
2024-09-10	H.C. Wainwright 26th Annual Global Investment Conference	Conference
2024-08-14	Longeveron 2024 Second Quarter Financial Results Call	Event
2024-07-02	Annual Meeting of Stockholders	Shareholder meeting
2024-06-20	Virtual Life Sciences Investor Forum	Event
2024-06-12	Emerging Growth Virtual Conference	Conference
2024-05-14	Longeveron 2024 First Quarter Financial Results Call	Event
2024-05-01	Planet MicroCap Showcase Presentation	Presentation
2024-02-27	Longeveron, Inc 2023 Fourth Quarter Earnings Call	Earnings call
2023-11-10	Longeveron, Inc 2023 Third Quarter Earnings Call	Earnings call
2023-08-16	Virtual KOL Event: Medicinal Signaling Cells (MSCs) for Hypoplastic Left Heart Syndrome (HLHS) with Lomecel-B™	Event
2023-05-12	Longeveron, Inc 2023 First Quarter Earnings Call	Earnings call
2023-03-10	Longeveron, Inc 2022 Fourth Quarter Earnings Call	Earnings call

Source: https://investors.longeveron.com/overview/default.aspx